Still, the agency authorized three more tomato-related claims to be used on product labels, saying there was "very limited credible evidence" they provide a health benefit. Like the prostate language, the authorized claims must be heavily qualified:
_Gastric cancer: "Four studies did not show that tomato intake reduces the risk of gastric cancer, but three studies suggest that tomato intake may reduce this risk. Based on these studies, FDA concludes that it is unlikely that tomatoes reduce the risk of gastric cancer."
_Ovarian cancer: "One study suggests that consumption of tomato sauce 2 times per week may reduce the risk of ovarian cancer; while this same study shows that consumption of tomatoes or tomato juice had no effect on ovarian cancer risk. FDA concludes that it is highly uncertain that tomato sauce reduces the risk of ovarian cancer."
_Pancreatic cancer: "One study suggests that consuming tomatoes does not reduce the risk of pancreatic cancer, but one weaker, more limited study suggests that consuming tomatoes may reduce this risk. Based on these studies, FDA concludes that it is highly unlikely that tomatoes reduce the risk of pancreatic cancer."
__
On the Net:
Food and Drug Administration: http://www.fda.gov/
American Longevity: http://www.americanlongevity.net/
H.J. Heinz Co.: http://www.heinz.com/
